McDermott Will & Emery·ANTITRUST / COMPETITION

FTC Details Scrutiny of 'Shop' Process for Failing Firm Defense

The head of the Federal Trade Commission has outlined five factors the agency will use to scrutinize the sale process of a financially distressed target in a merger, raising the bar for parties asserting the 'failing firm' defense.

In a statement prompted by a scuttled Ohio hospital merger, Federal Trade Commission Chairman Andrew Ferguson has detailed five factors the agency will scrutinize when evaluating the adequacy of a 'shop' process for a company asserting the 'failing firm' defense. The new guidance focuses on the third prong of the defense, which requires a good-faith effort to find an alternative buyer. The FTC will now explicitly assess whether the seller solicited a full set of potential buyers, gave them sufficient time and data for diligence, engaged in good-faith negotiations, and properly weighed less anticompetitive offers. This signals a more demanding standard for parties in all industries, not just healthcare. For sophisticated counsel, it means a pre-deal 'shop' process that is merely adequate may no longer suffice. Failure to conduct and document a robust and impartial search for alternative acquirers before signing with a direct competitor could prove fatal to a deal during the subsequent antitrust review, or at least cause significant delays and added expense.

ftcmerger-reviewantitrustfailing-firm-defensemahospital-mergers
Read the original firm alert → Tuesday, September 15, 2026

Stay ahead

Join the digest.

One email when the daily AmLaw 100 briefing ships. No noise, no pitch decks — just the grade 4–5 signal.